These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20805673)

  • 21. Eculizumab in paroxysmal nocturnal hemoglobinuria.
    Kathula SK
    N Engl J Med; 2006 Dec; 355(26):2786; author reply 2787-8. PubMed ID: 17192547
    [No Abstract]   [Full Text] [Related]  

  • 22. [Diagnosis and treatment of paroxysmal nocturnal hemoglobinuria].
    Kanakura Y
    Rinsho Ketsueki; 2009 Oct; 50(10):1469-76. PubMed ID: 19915356
    [No Abstract]   [Full Text] [Related]  

  • 23. The frequency of HLA class I alleles in Japanese patients with bone marrow failure.
    Shichishima T; Noji H; Ikeda K; Akutsu K; Maruyama Y
    Haematologica; 2006 Jun; 91(6):856-7. PubMed ID: 16704965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An altered gut microbiota may trigger autoimmune-mediated acquired bone marrow failure syndromes.
    Espinoza JL; Elbadry MI; Nakao S
    Clin Immunol; 2016 Oct; 171():62-64. PubMed ID: 27506961
    [No Abstract]   [Full Text] [Related]  

  • 25. Somatic mutation and clonal selection in the pathogenesis and in the control of paroxysmal nocturnal hemoglobinuria.
    Bessler M; Hillmen P
    Semin Hematol; 1998 Apr; 35(2):149-67. PubMed ID: 9565157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update in paroxysmal nocturnal hemoglobinuria.
    Hillmen P
    Clin Adv Hematol Oncol; 2012 Jun; 10(6):391-3. PubMed ID: 22895241
    [No Abstract]   [Full Text] [Related]  

  • 27. Improving renal outcomes in chronic anemia: learning from paroxysmal nocturnal hemoglobinuria.
    Guasch A
    Am J Hematol; 2010 Aug; 85(8):551-2. PubMed ID: 20658585
    [No Abstract]   [Full Text] [Related]  

  • 28. Somatic MECOM mosaicism in a patient with congenital bone marrow failure without a radial abnormality.
    Osumi T; Tsujimoto SI; Nakabayashi K; Taniguchi M; Shirai R; Yoshida M; Uchiyama T; Nagasawa J; Goyama S; Yoshioka T; Tomizawa D; Kurokawa M; Matsubara Y; Kiyokawa N; Matsumoto K; Hata K; Kato M
    Pediatr Blood Cancer; 2018 Jun; 65(6):e26959. PubMed ID: 29356389
    [No Abstract]   [Full Text] [Related]  

  • 29. A cohort study of the nature of paroxysmal nocturnal hemoglobinuria clones and PIG-A mutations in patients with aplastic anemia.
    Wanachiwanawin W; Siripanyaphinyo U; Piyawattanasakul N; Kinoshita T
    Eur J Haematol; 2006 Jun; 76(6):502-9. PubMed ID: 16529603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unusual Anemias.
    Daughety MM; DeLoughery TG
    Med Clin North Am; 2017 Mar; 101(2):417-429. PubMed ID: 28189179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soluble NKG2D Ligands Are Potential Biomarkers and Sentinels of Immune-Mediated Bone Marrow Injury in Bone Marrow Failure Syndromes.
    Murata S; Mushino T; Hosoi H; Kuriyama K; Nishikawa A; Nagakura S; Horikawa K; Yonemura Y; Nakakuma H; Sonoki T; Hanaoka N
    Acta Haematol; 2020; 143(1):33-39. PubMed ID: 31216534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Paroxysmal nocturnal hemoglobinuria].
    Nishimura J
    Rinsho Ketsueki; 2012 Jan; 53(1):15-24. PubMed ID: 22374521
    [No Abstract]   [Full Text] [Related]  

  • 33. A closer look at paroxysmal nocturnal hemoglobinuria.
    Rachidi S; Musallam KM; Taher AT
    Eur J Intern Med; 2010 Aug; 21(4):260-7. PubMed ID: 20603032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paroxysmal nocturnal hemoglobinuria and eculizumab.
    Luzzatto L; Risitano AM; Notaro R
    Haematologica; 2010 Apr; 95(4):523-6. PubMed ID: 20378572
    [No Abstract]   [Full Text] [Related]  

  • 35. Paroxysmal nocturnal hemoglobinuria: the price for a chance.
    Bessler M
    Schweiz Med Wochenschr; 1996 Nov; 126(45):1912-21. PubMed ID: 8946596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eculizumab opens a new era of treatment for paroxysmal nocturnal hemoglobinuria.
    Schrezenmeier H; Höchsmann B
    Expert Rev Hematol; 2009 Feb; 2(1):7-16. PubMed ID: 21082989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [PAROXYSMAL NOCTURNAL HEMOGLOBINURIA. REPORT OF 8 CASES WITH SPECIAL REGARD TO PANTOCYTOPENIA AND BONE MARROW APLASIA].
    CHROBAK L; BRABEE V; WIEDERMANN B; DONNER L; FRIEDMANN B; PUDLAK P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1964; 82():256-93. PubMed ID: 14342555
    [No Abstract]   [Full Text] [Related]  

  • 38. Successful use of eculizumab in a pediatric patient treated for paroxysmal nocturnal hemoglobinuria.
    Bauters T; Bordon V; Robays H; Benoit Y; Dhooge C
    J Pediatr Hematol Oncol; 2012 Nov; 34(8):e346-8. PubMed ID: 22767128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evidence of the efficacy of eculizumab in paroxysmal nocturnal hemoglobinuria].
    Nau JY
    Rev Med Suisse; 2006 Oct; 2(81):2255. PubMed ID: 17076159
    [No Abstract]   [Full Text] [Related]  

  • 40. Eculizumab in paroxysmal nocturnal hemoglobinuria.
    Pride YB
    N Engl J Med; 2006 Dec; 355(26):2787; author reply 2787-8. PubMed ID: 17195305
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.